NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

失眠藥物治療的全球市場:按治療進行的市場調查(非處方助眠藥和處方助眠藥),展望(-2025年),COVID-19的累積影響

Insomnia Pharmacological Treatment Market Research Report by Treatment, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 973187
出版日期 內容資訊 英文 182 Pages
商品交期: 最快1-2個工作天內
價格
失眠藥物治療的全球市場:按治療進行的市場調查(非處方助眠藥和處方助眠藥),展望(-2025年),COVID-19的累積影響 Insomnia Pharmacological Treatment Market Research Report by Treatment, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 182 Pages
簡介

失眠藥物治療的市場規模預計將從2019年的7,148.13百萬美元增長到5.67%的年均增長率(CAGR),到2025年底達到9,952.73百萬美元。

市場細分和覆蓋率

該研究報告對失眠的藥物治療進行了分類,預測了利潤並分析了以下每個子市場的趨勢。

  • 治療在子市場中,市場分為非處方睡眠助劑和處方睡眠助劑。通過抗組胺藥,褪黑激素和纈草根進一步對非處方睡眠助劑進行分類和調查。規定的睡眠助劑被分類和研究為苯二氮卓類,褪黑激素受體拮抗劑,非苯二氮卓類和油性毒素拮抗劑。
  • 按地區將其分類並調查了美洲,亞太地區,歐洲和中東/非洲。美洲地區正在阿根廷,巴西,加拿大,墨西哥和美國進行調查。在澳大利亞,中國,印度,印度尼西亞,日本,馬來西亞,菲律賓,韓國和泰國對亞太地區進行了調查。歐洲是法國,德國,西班牙,意大利,荷蘭,俄羅斯和英國,而中東和非洲是卡塔爾,沙特阿拉伯,南非和阿拉伯聯合酋長國。

企業可用性概況

該調查由EEbb Therapeutics、Eisai Co.、Ltd.、Meda Consumer Healthcare, Inc、Merck & Co., Inc.、Mylan NV、Paratek Pharmaceuticals, Inc.、 Pernix Therapeutics、 Pfizer Inc.、 Purdue Pharmaceuticals L.P.、 Sanofi S.A.、 Sumitomo Dainippon Pharma Co., Ltd.、 Takeda Pharmaceuticals Company Ltd.、れプヂVanda Pharmaceuticals.都在深入探索全球市場領先廠商最近的重大發展和創新概況。

FPNV定位矩陣

FPNV定位矩陣可幫助公司製定更好的決策,並通過業務戰略(業務增長,行業覆蓋範圍,財務可行性,渠道支持)和產品滿意度來瞭解競爭格局。根據(成本性能,易用性,產品功能和客戶支持)對我們市場中的供應商進行評估和分類。

競爭戰略窗口(競爭戰略窗口)

競爭戰略窗口從市場,應用和區域角度分析了競爭格局。這有助於供應商定義能力和機會之間的協調或適應,以實現未來的增長前景。在預測期內,供應商將採用持續的併購策略,區域擴展,研發和新產品實施策略,以最佳或有利地適應進一步的業務擴展和增長。

COVID-19的累積影響

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。這項研究提供了對COVID-19的見解,同時考慮了不斷變化的消費者行為和需求,購買模式,供應鏈重新路由,當前市場勢力動態以及政府的關鍵干預措施。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

該調查提供了有關以下準則的見解:

  • 1.市場滲透率:主要參與者提供的有關市場的全面信息
  • 2.市場開發:有利可圖的新興市場的詳細信息和市場分析
  • 3.市場多元化:有關新產品發佈,欠發達地區,最新發展和投資的更多信息
  • 4.競爭評估和情報:全面評估主要公司的市場份額,戰略,產品和製造能力
  • 5.產品開發和創新:對未來技術,研發活動和新產品開發的智能見解

該調查回答了以下問題

  • 1. 失眠藥物治療的全球市場規模和預測是什麼?
  • 2. 在預測期內,構成市場的COVID-19有哪些障礙和影響?
  • 3. 在預測期內,您將投資哪些產品,細分,應用或領域?
  • 4. 什麼是市場機會的競爭戰略窗口?
  • 5. 什麼是市場技術趨勢和監管框架?
  • 6. 您認為適合進入市場的方式和戰略舉措是什麼?

本報告調查了失眠藥物治療的全球市場,概述了市場,分析了市場增長和障礙,市場機會,市場規模趨勢以及按治療和地區,競爭情況做出的預測,它提供系統信息,例如主要公司的概況。

目錄

第1章序言

  • 調查目的
  • 市場細分和覆蓋範圍
  • 調查對像年度
  • 貨幣和價格
  • 語言
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 配方:數據驗證
    • 發佈:調查報告
    • 重複:更新報告
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 簡介
  • 市場前景
  • 治療前景
  • 區域展望
  • 競爭對手展望

第4章市場概述

  • 簡介

第5章市場動態

  • 簡介
  • 促進因素
    • 壓力增加和身體殘疾
    • 成人慢性失眠的患病率
    • 增強患者對失眠的認識並增加就診
  • 抑製器
    • 藥物相關的副作用
  • 市場機會
    • 新產品開發
    • 新藥在發展中地區的滲透率提高
  • 挑戰
    • 在某些患者中失眠的個人水平污名

第6章市場洞察

  • 波特五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭
  • COVID-19的累積效果
  • 客戶端定制

第7章按治療

  • 簡介
  • 非處方睡眠幫助
    • 抗組胺藥
    • 褪黑激素
    • 纈草根
  • 處方助眠藥
    • 苯二氮卓
    • 褪黑激素受體拮抗劑
    • 非苯二氮卓
    • Orexin拮抗劑

第8章美洲

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區

  • 簡介
  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章歐洲,中東/非洲

  • 簡介
  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第11章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場佔有率分析
  • 競爭情景
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,表彰,擴展

第12章企業可用性簡介

  • Ebb Therapeutics
  • Eisai Co., Ltd.
  • Meda Consumer Healthcare, Inc
  • Merck & Co., Inc.
  • Mylan N.V.
  • Paratek Pharmaceuticals, Inc.
  • Pernix Therapeutics
  • Pfizer Inc.
  • Purdue Pharmaceuticals L.P.
  • Sanofi S.A.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Takeda Pharmaceuticals Company Ltd.
  • Vanda Pharmaceuticals

第13章附錄

  • 討論指南

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-FB6C9E792FFF

The Global Insomnia Pharmacological Treatment Market size was estimated at USD 7,530.46 Million in 2020 and expected to reach USD 7,985.76 Million in 2021, at a Compound Annual Growth Rate (CAGR) 6.38% to reach USD 10,916.69 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Insomnia Pharmacological Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment, the Insomnia Pharmacological Treatment Market was studied across Over-the-Counter Sleep Aids and Prescription Sleep Aids. The Over-the-Counter Sleep Aids is further studied across Antihistamines, Melatonin, and Valerian Roots. The Prescription Sleep Aids is further studied across Benzodiazepines, Melatonin Receptor Antagonists, Non-benzodiazepines, and Orexin Antagonists.

Based on Geography, the Insomnia Pharmacological Treatment Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Insomnia Pharmacological Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Insomnia Pharmacological Treatment Market, including Aa Pharma Inc, Actavis Totowa LLC, Altimed Pharma Inc., Amneal Pharmaceuticals NY LLC, Direct_Rx, Ebb Therapeutics, Eisai Co., Ltd., Foxland Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Hospira, Inc., Ingenus Pharmaceuticals, LLC, Meda Consumer Healthcare, Inc, MEDA Pharmaceuticals, MedPointe Pharmaceuticals, Merck & Co., Inc., Micro Labs Limited, Mylan N.V., Paratek Pharmaceuticals, Inc., Pernix Therapeutics, Pfizer Inc., Pro Doc Limitee, Purdue Pharmaceuticals L.P., Remedy Repack, Sanofi S.A., Sivem Pharmaceuticals Ulc, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceuticals Company Ltd., TriVue Pharmaceuticals, Inc., Vanda Pharmaceuticals, and Winthrop U.S..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Insomnia Pharmacological Treatment Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insomnia Pharmacological Treatment Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insomnia Pharmacological Treatment Market?
  • 4. What is the competitive strategic window for opportunities in the Global Insomnia Pharmacological Treatment Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Insomnia Pharmacological Treatment Market?
  • 6. What is the market share of the leading vendors in the Global Insomnia Pharmacological Treatment Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Insomnia Pharmacological Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Treatment Outlook
  • 3.4. Geography Outlook
  • 3.5. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing stress level and physical disorders
      • 5.1.1.2. Prevalence of chronic insomnia in adult patients
      • 5.1.1.3. Rising awareness among patient and increasing visits to doctor regarding to insomnia
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel products
      • 5.1.3.2. Increase in penetration of new pharmaceuticals in developing areas
    • 5.1.4. Challenges
      • 5.1.4.1. Individual level stigma about insomnia in some patients
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Insomnia Pharmacological Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Over-the-Counter Sleep Aids
    • 6.2.1. Antihistamines
    • 6.2.2. Melatonin
    • 6.2.3. Valerian Roots
  • 6.3. Prescription Sleep Aids
    • 6.3.1. Benzodiazepines
    • 6.3.2. Melatonin Receptor Antagonists
    • 6.3.3. Non-benzodiazepines
      • 6.3.3.1. Eszopiclone
      • 6.3.3.2. Zaleplon
      • 6.3.3.3. Zolpidem
    • 6.3.4. Orexin Antagonists

7. Americas Insomnia Pharmacological Treatment Market

  • 7.1. Introduction
  • 7.2. Argentina
  • 7.3. Brazil
  • 7.4. Canada
  • 7.5. Mexico
  • 7.6. United States
    • 7.6.1. California
    • 7.6.2. Florida
    • 7.6.3. Illinois
    • 7.6.4. New York
    • 7.6.5. Ohio
    • 7.6.6. Pennsylvania
    • 7.6.7. Texas

8. Asia-Pacific Insomnia Pharmacological Treatment Market

  • 8.1. Introduction
  • 8.2. China
  • 8.3. India
  • 8.4. Indonesia
  • 8.5. Japan
  • 8.6. Malaysia
  • 8.7. Philippines
  • 8.8. South Korea
  • 8.9. Thailand

9. Europe, Middle East & Africa Insomnia Pharmacological Treatment Market

  • 9.1. Introduction
  • 9.2. France
  • 9.3. Germany
  • 9.4. Italy
  • 9.5. Netherlands
  • 9.6. Qatar
  • 9.7. Russia
  • 9.8. Saudi Arabia
  • 9.9. South Africa
  • 9.10. Spain
  • 9.11. United Arab Emirates
  • 9.12. United Kingdom

10. Competitive Landscape

  • 10.1. FPNV Positioning Matrix
    • 10.1.1. Quadrants
    • 10.1.2. Business Strategy
    • 10.1.3. Product Satisfaction
  • 10.2. Market Ranking Analysis
  • 10.3. Market Share Analysis, By Quadrant
  • 10.4. Market Share Analysis, By Company
  • 10.5. Competitive Scenario
    • 10.5.1. Merger & Acquisition
    • 10.5.2. Agreement, Collaboration, & Partnership
    • 10.5.3. New Product Launch & Enhancement
    • 10.5.4. Investment & Funding
    • 10.5.5. Award, Recognition, & Expansion

11. Company Usability Profiles

  • 11.1. Aa Pharma Inc
  • 11.2. Actavis Totowa LLC
  • 11.3. Altimed Pharma Inc.
  • 11.4. Amneal Pharmaceuticals NY LLC
  • 11.5. Direct_Rx
  • 11.6. Ebb Therapeutics
  • 11.7. Eisai Co., Ltd.
  • 11.8. Foxland Pharmaceuticals, Inc.
  • 11.9. Fresenius Kabi USA, LLC
  • 11.10. Hospira, Inc.
  • 11.11. Ingenus Pharmaceuticals, LLC
  • 11.12. Meda Consumer Healthcare, Inc
  • 11.13. MEDA Pharmaceuticals
  • 11.14. MedPointe Pharmaceuticals
  • 11.15. Merck & Co., Inc.
  • 11.16. Micro Labs Limited
  • 11.17. Mylan N.V.
  • 11.18. Paratek Pharmaceuticals, Inc.
  • 11.19. Pernix Therapeutics
  • 11.20. Pfizer Inc.
  • 11.21. Pro Doc Limitee
  • 11.22. Purdue Pharmaceuticals L.P.
  • 11.23. Remedy Repack
  • 11.24. Sanofi S.A.
  • 11.25. Sivem Pharmaceuticals Ulc
  • 11.26. Sumitomo Dainippon Pharma Co., Ltd.
  • 11.27. Takeda Pharmaceuticals Company Ltd.
  • 11.28. TriVue Pharmaceuticals, Inc.
  • 11.29. Vanda Pharmaceuticals
  • 11.30. Winthrop U.S.

12. Appendix

  • 12.1. Discussion Guide
  • 12.2. License & Pricing
  • 12.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MARKET DYNAMICS
  • FIGURE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2026 (%)
  • FIGURE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2026
  • FIGURE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 34. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 36. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. CALIFORNIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. FLORIDA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. ILLINOIS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. NEW YORK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. OHIO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. PENNSYLVANIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. TEXAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 49. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 51. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 62. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: FPNV POSITIONING MATRIX
  • FIGURE 74. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 75. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CALIFORNIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. FLORIDA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. ILLINOIS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. NEW YORK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. OHIO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. PENNSYLVANIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. TEXAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: SCORES
  • TABLE 55. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: BUSINESS STRATEGY
  • TABLE 56. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PRODUCT SATISFACTION
  • TABLE 57. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RANKING
  • TABLE 58. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 59. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • TABLE 60. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MERGER & ACQUISITION
  • TABLE 61. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 62. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 63. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: INVESTMENT & FUNDING
  • TABLE 64. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 65. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: LICENSE & PRICING
  • TABLE 66. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: CONTACT DETAILS